Alexander D. Macrae
2018
In 2018, Alexander D. Macrae earned a total compensation of $4.1M as President and Chief Executive Officer at Sangamo Biosciences, a 129% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $420,077 |
|---|---|
| Option Awards | $2,410,657 |
| Salary | $636,480 |
| Stock Awards | $631,575 |
| Other | $5,639 |
| Total | $4,104,428 |
Macrae received $2.4M in option awards, accounting for 59% of the total pay in 2018.
Macrae also received $420.1K in non-equity incentive plan, $636.5K in salary, $631.6K in stock awards and $5.6K in other compensation.
Rankings
In 2018, Alexander D. Macrae's compensation ranked 2,700th out of 14,244 executives tracked by ExecPay. In other words, Macrae earned more than 81.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,700 out of 14,244 | 81st |
Division Manufacturing | 1,000 out of 5,765 | 83rd |
Major group Chemicals And Allied Products | 347 out of 2,128 | 84th |
Industry group Drugs | 284 out of 1,817 | 84th |
Industry Biological Products, Except Diagnostic Substances | 60 out of 339 | 82nd |
Source: SEC filing on April 1, 2020.
Macrae's colleagues
We found two more compensation records of executives who worked with Alexander D. Macrae at Sangamo Biosciences in 2018.